SCHEMBL6525700

SCHEMBL6525700

C=C(c1cccc(Cl)c1)c1ccccc1C=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 2/20 0.41
POLB P06746 1/20 0.41
KDM1A O60341 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
ERN1 O75460 2/20 0.39
KCNK3 O14649 1/20 0.38
KCNK9 Q9NPC2 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
MAOB P27338 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6520356 0.82 NR4A1 (0.42) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL10978285 0.81 KMT2A (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2ERN1
SCHEMBL1794480 0.75 PARP1 (0.56) PARP1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1663839 0.75 CES2 (0.45) ALDH1A1MEN1KMT2ARAB9APOLB
SCHEMBL7763955 0.74 PARP1 (0.50) PARP1MEN1KMT2ARAB9ANPC1
SCHEMBL6120523 0.72 UNG (0.49) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL4557072 0.71 TDP1 (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2ERN1
SCHEMBL7129303 0.71 POLB (0.53) PARP1ALDH1A1MEN1KMT2ARAB9A
SCHEMBL13539222 0.70 CTNNB1 (0.47) RAB9ANPC1GAAMAPT
SCHEMBL3446883 0.69 PARP1 (0.59) PARP1ALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680150-B2 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors LIGAND PHARMACEUTICALS, INC. (US) 2014-03-25 US disclosed
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS LIGAND PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS MPL, CSF3R, CSF1R PARP1 3267/4885ALDH1A1 3164/4885MEN1 1652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.